FIELD: pharmaceuticals.
SUBSTANCE: invention relates to an isotonic crystalloid aqueous solution. Solution contains Na+ ions in range of 50 to 200 mmol/l, K+ ions in range of 1 to 10 mmol/l, ions Cl− in range from 50 to 200 mmol/l of nitrate ions or nitrite ions, or their mixture in range of 0.0001 to 1 mmol/l and chemical elements: Li, Be, B, Al, Si, P, Sc, V, Cr, Mn, Fe, Co, Ni, Cu, Zn, As, Br, Rb, Sr, Y, Zr, Mo, Pd, Ag, Sn, Sb, I, Cs, Ba, Ce, Au, Tl, Pb, Bi, Th and U. Also disclosed is use of said solution for treating haemorrhagic shock.
EFFECT: solution according to present invention has the ability to form nitrogen oxide, recovering microcirculation without disturbed macrocirculation or any other toxic effects and can be used for treating haemorrhagic shock.
7 cl, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| INFUSION SOLUTION | 2019 |
|
RU2708389C1 |
| PROTECTIVE COMPOSITIONS FOR ISCHEMIA/REPERFUSION AND METHODS FOR USING THEM | 2008 |
|
RU2459624C2 |
| METHOD OF SHOCK TREATMENT | 1989 |
|
RU2012333C1 |
| METHOD OF TREATING HEMORRHAGIC SHOCK OF I, II AND III DEGREE OF SEVERITY | 2011 |
|
RU2482840C2 |
| METHOD OF TREATING TRAUMATIC SHOCK OF III SEVERITY DEGREE | 2018 |
|
RU2677333C1 |
| COMBINATION THERAPY FOR TREATING HEMORRHAGIC SHOCK | 2018 |
|
RU2663464C1 |
| ISOTONIC INFUSION SOLUTION | 2020 |
|
RU2744331C1 |
| COMBINATION THERAPY FOR TREATING HEMORRHAGIC SHOCK | 2015 |
|
RU2651778C2 |
| MULTICOMPONENT INFUSION SOLUTION OF ELECTROLYTES IN COMBINATION WITH BIOLOGICALLY ACTIVE COMPONENTS FOR INTRAVENOUS ADMINISTRATION | 2022 |
|
RU2796724C1 |
| METHOD FOR PATHOGENETICALLY JUSTIFIED EVALUATION OF HYPOVOLEMIA FOR PATIENTS WITH II AND III SEVERITY TRAUMATIC SHOCK | 2016 |
|
RU2618200C1 |
